Conference Description:

Be at the forefront of the insights from 60+ leading experts as they share their learnings on:

Commercialization challenges, the payers perspective and the investors’ criteria for business in the current and future NASH market

The non-invasive diagnostics landscape and regulatory considerations on biomarker adoption for clinical trials

Computational methods and artificial intelligence to increase the efficiency of drug development

Scientific rationale of combinational therapeutics as the necessary treatment strategy for NASH to inform pairing decisions

Identification and recruitment of “high risk” patients needed to optimize clinical success and demonstrate sufficient efficacy

Prices:
Gold Pass: Full Access (Conference Days + Seminar Day & 2 Workshops) USD 4797.0
Silver Pass: Conference + 1 Seminar USD 4098.0
Silver Pass: Conference + 2 Workshops: USD 4098.0
Bronze Pass: Conference Only USD 2999.0
Bronze Pass: Seminar Day Only USD 1399.0
Bronze Pass: 2 Workshops Only USD 1399.0

Time: on Monday April 22, 2019 at 8:00 am (ends Thursday April 25, 2019 at 5:00 pm)